This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring a fluorine atom and a dihydrobenzofuran ring, makes it valuable in the development of drugs targeting central nervous system disorders, such as depression, anxiety, and neurodegenerative diseases. Additionally, it is employed in the creation of selective serotonin reuptake inhibitors (SSRIs) and other psychotropic medications due to its ability to modulate neurotransmitter activity. Its chiral nature also allows for the production of enantiomerically pure compounds, enhancing the efficacy and reducing side effects of the resulting drugs.